Proposed Data Collections Submitted for Public Comment and Recommendations, 33498-33499 [05-11371]
Download as PDF
<![CDATA[
33498
Federal Register / Vol. 70, No. 109 / Wednesday, June 8, 2005 / Notices
received their health insurance coverage
through federally funded State Medicaid
programs; approximately 11.5 million
(36%) of these persons smoked. The
amount and type of coverage for
tobacco-dependence treatment offered
by Medicaid has been reported for 1998
and annually from 2000–2003. In 2002
and 2003, surveys were funded by the
Robert Wood Johnson Foundation
(RWJF). RWJF will no longer be tracking
this coverage; therefore, CDC proposes
to fund the survey. CDC proposed to
fund the survey from 2004–2010. The
survey will allow CDC to continue to
measure progress of State Medicaid
Programs toward the 2010 National
Health Objective and document changes
in the provision of coverage toward
reaching the Healthy People 2010 goal.
The objectives of the project are as
follows:
• Conduct a study of all 50 states and
the District of Columbia Medicaid
Programs to determine coverage for
tobacco dependence treatment
(counseling and FDA-approved
pharmacotherapies) and assess
compliance with the PHS
recommendations.
• Analyze and publish the data.
Medicaid recipients have
approximately 50% greater smoking
prevalence than the overall U.S. adult
population, and they are
disproportionately affected by tobaccorelated disease and disability.
Substantial action to improve coverage
will be needed if the United States is to
Proposed Project
State Medicaid Survey—New—
National Center for Chronic Disease
Prevention and Control (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The proposed 2004 State Medicaid
Survey will assess State Medicaid
Programs to determine the extent of
coverage for tobacco-dependence
treatment. Tobacco use is the leading
preventable cause of death in the United
States. One of the 2010 National Health
Objectives is to increase insurance
coverage of evidence-based treatment
for nicotine dependence (i.e., Food and
Drug Administration [FDA]-approved
pharmacotherapies and total coverage of
behavioral therapies in Medicaid
programs) from 36 states to all 50 states
and the District of Columbia. To
increase both the use of treatment by
smokers attempting to quit and the
number of smokers who quit
successfully, the Guide to Community
Preventive Services recommends
reducing the out-of-pocket cost of
effective tobacco-dependence treatments
(i.e., individual, group and telephone
counseling and FDA-approved
pharmacotherapies). The 2000 Public
Health Service (PHS) Clinical Practice
Guideline supports expanded insurance
coverage for tobacco-dependence
treatment.
In 2000, approximately 32 million
low-income persons in the United States
achieve the 2010 National Health
Objective of 12% smoking prevalence
among adults.
This project will provide an
opportunity to assess the extent of
coverage for tobacco-dependence
treatment under Medicaid. In 2002, 36
states provided coverage for some FDA
approved medications; however, only
10 states provided some form of
coverage for counseling and only 2
states provided comprehensive
coverage, counseling and medication.
Fifteen states provided no coverage.
This project will be conducted with a
mailed request to State Medicaid
directors to identify a knowledgeable
person within their system to respond to
the survey. The survey will be mailed to
the identified individuals.
Respondents will be asked to submit
a written copy of their Medicaid
coverage policies. If responses are not
received, individuals will receive a
telephone follow-up. Respondents are
mailed the survey that they completed
the previous year and asked to make
revisions if changes have occurred. If
this is being done by the person who
completed the survey the previous year,
the response burden is reduced. If the
questions are not answered or not
answered clearly, follow-up is required
which takes additional time. All 50
states plus the District of Columbia have
reported in the past. There is no cost to
respondents except the time to complete
the survey. The estimated total burden
hours are 26.45.
ESTIMATE OF ANNUALIZED BURDEN TABLE
Respondents
No. of
respondents
No. of
responses per
respondent
Average burden
per response
(in hrs)
State Medicaid Directors ...........................................................................................
State Medicaid Programs with Minimal Response ....................................................
State Medicaid Programs with Maximum Response ................................................
51
35
16
1
1
1
2/60
15/60
1
Dated: May 31, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–11370 Filed 6–7–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
[30Day–05–0445X]
Centers for Disease Control and
Prevention
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
VerDate jul<14>2003
18:08 Jun 07, 2005
Jkt 205001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
requests, call the CDC Reports Clearance
Officer at (404) 371–5983 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Human
Resources and Housing Branch, New
Executive Office Building, Room 10235,
Washington, DC 20503 or by fax to (202)
395–6974. Written comments should be
received within 30 days of this notice.
Proposed Project
A Multi-Center Study to Assess
Exposure to Environmental Pollutants
Among Primiparous Women in North
America—New—National Center for
Environmental Health (NCEH), Centers
for Disease Control and Prevention
(CDC).
E:\FR\FM\08JNN1.SGM
08JNN1
33499
Federal Register / Vol. 70, No. 109 / Wednesday, June 8, 2005 / Notices
Background and Brief Description
Persistent organic pollutants (POPs)
are a group of man-made chemicals that
can stay in the environment for long
periods of time and can be transported
long distances in the environment.
Heavy metals such as lead and mercury
are naturally found substances that can
also be released into the environment as
a result of human activities (e.g.,
smelting). Exposure to these
contaminants, even at low levels, may
lead to adverse health effects,
particularly in high-risk groups such as
the unborn child. However, before we
attempt to determine if these
contaminants are associated with health
effects, we have to find out if these
contaminants are present in our blood
and in what amounts. The Arctic
Monitoring and Assessment Program
(AMAP), established in 1991 under the
Arctic Environmental Protection
Strategy (AEPS), has the responsibility
to monitor levels and assess effects of
selected pollutants (i.e., POPs and heavy
metals) in all Arctic locations. To our
knowledge, a similar integrated program
for monitoring exposure to POPs and
metals does not exist in North America.
The proposed program will monitor
levels of POPs and heavy metals in firsttime pregnant (Primiparous) women.
The program will help determine
geographical and temporal trends of
these exposures in selected cities within
the United States, Canada, and Mexico.
CDC will be responsible for the
investigation in the United States;
Canada and Mexico will be responsible
for the investigation in their countries.
The findings will inform first-time
pregnant women in the vicinity of the
study sites of their exposure to selected
POPs and heavy metals. This program
will also provide unique information
regarding accumulation of POPs and
heavy metals in relation to dietary
patterns, and will allow assessment of
trends in diet, which is critical public
health information. Biomonitoring for
POPs and metals will enhance
awareness among this vulnerable
population of the risks posed by these
chemicals in various regions of North
America and help identify ways to
reduce exposure. The program will
enroll 25 pregnant women (20–25 years
of age) per site (United States: 5 sites;
Canada: 5 sites; Mexico: 10 sites). The
current protocol only describes and
seeks approval for enrollment of 75
pregnant women from three of the five
U.S. sites. Two U.S. sites have ongoing
studies, in collaboration with CDC,
where they are testing maternal blood
for POPs and metals; these two sites are
non-federal, academic institutions, and
CDC does not have a formal funding
agreement with these institutions. Data
from previous projects in the United
States and Canada will be used for
comparing results of the current project.
As there has been little national or
regional monitoring in Mexico, more
sites will be selected in Mexico than in
the United States and Canada.
In collaboration with obstetricians at
the local sites, study participants will be
recruited during their prenatal clinic
visit, after their 36th week of pregnancy
but prior to delivery. One person from
the study team will approach the
mother during a routine prenatal visit,
explain the project, and obtain signed
consent if the mother is willing to
participate. The study will involve
administering an exposure
questionnaire and collection of blood
and urine samples during the 3rd
trimester of the pregnancy. This is only
a one-time study; blood collection and
administration of the questionnaire will
only be done once. All samples will be
analyzed at a single laboratory in each
country, and the results will be
distributed to the study participants and
their physicians prior to publication.
There are no costs to respondents other
than their time. The estimated total
annualized burden hours are 53 hours.
Estimate of Annualized Burden Table:
Type or respondents
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
Screening First-time Pregnant Women .......................................................................................
Demographic and Health History Questionnaire .........................................................................
Food Frequency Questionnaire ...................................................................................................
106
75
75
1
1
1
5/60
10/60
25/60
Dated: May 31, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–11371 Filed 6–7–05; 8:45 am]
BILLING CODE 4163–18–P
Executive Summary Demonstration of
Enhanced Services to Children and
Youth Who Have Been Exposed to
Domestic Violence
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Administration on Children, Youth and
Families, Family and Youth Services
Bureau; FY 2005 Discretionary Grants
for the Family Violence Prevention and
Services Program—Demonstration of
Enhanced Services to Children and
Youth Who Have Been Exposed to
Domestic Violence
Announcement Type: Initial.
VerDate jul<14>2003
18:08 Jun 07, 2005
Jkt 205001
Funding Opportunity Number: HHS–
2005–ACF–ACYF–EV–0031.
CFDA Number: 93.592.
Due Date For Letter of Intent: Letter of
Intent is due June 29, 2005.
Due Date for Applications:
Application is due July 25, 2005.
The Administration for Children and
Families (ACF) announces this funding
opportunity to offer awards for the
demonstration of enhanced services for
children and youth who have been
exposed to domestic violence.
I. Funding Opportunity Description
Authorizing Statutes and Regulations:
The Family Violence Prevention and
Services Act (the Act) was originally
enacted in sections 301–313 of Title III
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
of the ‘‘Child Abuse Amendments of
1984’’ (Pub. L. 98–457, 10/9/84). The
Act was most recently amended by the
‘‘Keeping Children and Families Safe
Act of 2003’’ (Pub. L. 108–36).
Program and Focus Areas: It is the
purpose of these demonstration grants
to provide enhanced services and
support to the children and youth who
have been exposed to domestic violence
in order to mitigate the impact of that
exposure and increase the opportunity
for these children and youth to lead
healthy, non-violent, and safe lives as
adults. The proposed demonstrations
require the collaboration of the State
agency that administers the family
violence prevention and services
programs and the State domestic
violence coalition within that state. The
collaboration need not be limited to the
above entities but must include them as
principal participants. The lead
applicant may be the coalition or the
E:\FR\FM\08JNN1.SGM
08JNN1
]]>Agencies
[Federal Register Volume 70, Number 109 (Wednesday, June 8, 2005)]
[Notices]
[Pages 33498-33499]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11371]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-05-0445X]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 371-5983 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Human
Resources and Housing Branch, New Executive Office Building, Room
10235, Washington, DC 20503 or by fax to (202) 395-6974. Written
comments should be received within 30 days of this notice.
Proposed Project
A Multi-Center Study to Assess Exposure to Environmental Pollutants
Among Primiparous Women in North America--New--National Center for
Environmental Health (NCEH), Centers for Disease Control and Prevention
(CDC).
[[Page 33499]]
Background and Brief Description
Persistent organic pollutants (POPs) are a group of man-made
chemicals that can stay in the environment for long periods of time and
can be transported long distances in the environment. Heavy metals such
as lead and mercury are naturally found substances that can also be
released into the environment as a result of human activities (e.g.,
smelting). Exposure to these contaminants, even at low levels, may lead
to adverse health effects, particularly in high-risk groups such as the
unborn child. However, before we attempt to determine if these
contaminants are associated with health effects, we have to find out if
these contaminants are present in our blood and in what amounts. The
Arctic Monitoring and Assessment Program (AMAP), established in 1991
under the Arctic Environmental Protection Strategy (AEPS), has the
responsibility to monitor levels and assess effects of selected
pollutants (i.e., POPs and heavy metals) in all Arctic locations. To
our knowledge, a similar integrated program for monitoring exposure to
POPs and metals does not exist in North America.
The proposed program will monitor levels of POPs and heavy metals
in first-time pregnant (Primiparous) women. The program will help
determine geographical and temporal trends of these exposures in
selected cities within the United States, Canada, and Mexico. CDC will
be responsible for the investigation in the United States; Canada and
Mexico will be responsible for the investigation in their countries.
The findings will inform first-time pregnant women in the vicinity of
the study sites of their exposure to selected POPs and heavy metals.
This program will also provide unique information regarding
accumulation of POPs and heavy metals in relation to dietary patterns,
and will allow assessment of trends in diet, which is critical public
health information. Biomonitoring for POPs and metals will enhance
awareness among this vulnerable population of the risks posed by these
chemicals in various regions of North America and help identify ways to
reduce exposure. The program will enroll 25 pregnant women (20-25 years
of age) per site (United States: 5 sites; Canada: 5 sites; Mexico: 10
sites). The current protocol only describes and seeks approval for
enrollment of 75 pregnant women from three of the five U.S. sites. Two
U.S. sites have ongoing studies, in collaboration with CDC, where they
are testing maternal blood for POPs and metals; these two sites are
non-federal, academic institutions, and CDC does not have a formal
funding agreement with these institutions. Data from previous projects
in the United States and Canada will be used for comparing results of
the current project. As there has been little national or regional
monitoring in Mexico, more sites will be selected in Mexico than in the
United States and Canada.
In collaboration with obstetricians at the local sites, study
participants will be recruited during their prenatal clinic visit,
after their 36th week of pregnancy but prior to delivery. One person
from the study team will approach the mother during a routine prenatal
visit, explain the project, and obtain signed consent if the mother is
willing to participate. The study will involve administering an
exposure questionnaire and collection of blood and urine samples during
the 3rd trimester of the pregnancy. This is only a one-time study;
blood collection and administration of the questionnaire will only be
done once. All samples will be analyzed at a single laboratory in each
country, and the results will be distributed to the study participants
and their physicians prior to publication. There are no costs to
respondents other than their time. The estimated total annualized
burden hours are 53 hours.
Estimate of Annualized Burden Table:
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type or respondents Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
Screening First-time Pregnant Women.......................... 106 1 5/60
Demographic and Health History Questionnaire................. 75 1 10/60
Food Frequency Questionnaire................................. 75 1 25/60
----------------------------------------------------------------------------------------------------------------
Dated: May 31, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 05-11371 Filed 6-7-05; 8:45 am]
BILLING CODE 4163-18-P
